Risk up with amiodarone vs flecainide or sotalol among seniors with atrial fibrillation receiving apixaban or rivaroxaban.
Your search for apixaban returned 7 results
Asundexian is an investigational oral Factor XIa inhibitor.
Apixaban dominated enoxaparin and edoxaban; rivaroxaban was slightly more effective than apixaban
No substantial differences seen for other outcomes or for other direct oral anticoagulant comparisons
Apixaban and rivaroxaban are both factor Xa inhibitors.
Fewer compliance events seen with apixaban versus enoxaparin for extended-duration VTE prophylaxis after abdominopelvic oncologic surgery
Abelacimab is a highly selective, fully human monoclonal antibody designed to inhibit both factor XI and its activated form, factor XIa.